Your Health Questions
Answered by Professionals

First time peanut reactions can range from mild skin or digestive symptoms to severe anaphylaxis, so assessing personal and family risk, consulting a healthcare provider for allergy testing, and preparing an emergency plan with medications like antihistamines and an epinephrine auto injector are crucial. There are important steps to safely introduce peanuts and manage any reaction, so see below for the full science backed guide with detailed precautions and response protocols that could influence your next steps in care.

A FeNO breath test measures nitric oxide in exhaled air to gauge airway inflammation and high readings often indicate eosinophilic inflammation seen in asthma and predict responsiveness to inhaled corticosteroids. Several factors such as allergies, infections, smoking, medications and technique can affect your FeNO result and it must be interpreted alongside your symptoms, lung function tests and medical history. See below for more details on interpreting your reading and next steps in your care.

A dry cough persisting beyond four weeks often reflects post viral airway sensitivity, allergies, asthma, reflux, medications like ACE inhibitors, or more serious lung or heart conditions. Initial evaluation involves history, exam, chest X ray, spirometry, and blood tests, but there are important red flags, advanced diagnostics, and specialist referrals outlined below that could impact your next steps in care. See below to understand more.

Doctors typically prescribe Advair 250/50 for mild to moderate asthma or COPD when stepping up from low-dose inhaled steroids, and reserve Advair 500/50 for moderate to severe disease with persistent symptoms or frequent exacerbations. There are several factors to consider when balancing symptom control against higher steroid exposure. See below for more important details that could impact your next steps in managing your condition.

Airway clearance techniques, such as active breathing exercises, postural drainage, device-assisted methods and suctioning, help clear thick mucus, improve airflow and reduce infection risk during respiratory duress by splinting airways and enhancing cough effectiveness. There are several factors to consider, including your lung condition, symptom severity, available devices and personal tolerance. See below for important details to guide your next steps in respiratory care.

Persistent inflammation in severe asthma drives permanent airway remodeling—thickened walls, excess mucus production, increased smooth muscle and blood vessels—that underlies chronic symptoms and reduced lung function despite optimal therapy. These structural changes can limit reversibility and heighten exacerbation risk. There are many factors to consider and important details on diagnosis, treatment options and proactive strategies in the complete answer below.

Albuterol tolerance in severe asthma results from receptor desensitization, downregulation, and inflammation-driven signalling changes that blunt bronchodilator response and raise the risk of exacerbations. Early recognition helps prevent over-reliance on rescue inhalers and masking of worsening airway inflammation. See below for a full overview of risk factors, prevention strategies, and when to seek medical advice.

Indoor allergic asthma triggers include dust mites, pet dander, mold spores, cockroach allergens, indoor pollen and chemical irritants, and identifying the ones that worsen your symptoms relies on careful monitoring of your home and personal reactions. There are several factors to consider. See below to understand more. Science-backed steps such as using allergen-proof bedding covers, HEPA vacuums, dehumidifiers, exhaust fans, sealed food storage and low-VOC products, along with regular cleaning and ventilation, can significantly reduce indoor triggers. For full guidance on eradication steps and next steps in your healthcare journey, see below.

Allergic bronchopulmonary aspergillosis is an immune-mediated lung reaction to Aspergillusfumigatus that often presents as worsening asthma, persistent cough with brownish mucus plugs, fleeting infiltrates on imaging, and high IgE and eosinophil levels. Early detection lets specialists use corticosteroids and antifungals to control inflammation and prevent permanent airway damage. There are many critical details about risk factors, diagnostic criteria, and long-term management that could influence your next steps in care. See below for complete information.

A positive ANA in chronic hives prompts evaluation for autoimmune urticaria and systemic conditions through detailed history, physical exam, and targeted tests such as ENA antibodies, complement levels, blood counts, thyroid studies, and sometimes skin biopsy. While many low-titer positives are incidental, high-titer ANAs or abnormal lab or urine findings may indicate lupus, thyroid disease, or vasculitis and lead to rheumatology referral and tailored treatment. There are several factors to consider, and you can find complete details on testing, interpretation, and treatment options below.

Infant hives after formula feeding are commonly caused by an allergic reaction to proteins like cow’s milk or additives, resulting in raised, itchy welts within minutes to hours. Initial steps include pausing the suspected formula, noting feeding and reaction details, and monitoring for any severe symptoms. There are several factors to consider; see below for complete details on safe formula alternatives, symptom management, and when to seek emergency care.

An oral food challenge is the gold standard method for accurately diagnosing or ruling out food allergies by administering gradually increasing doses of a suspected allergen under close medical supervision. Clinics follow strict safety protocols, including pre challenge assessments, a structured dose escalation schedule, emergency preparedness, and continuous monitoring, to minimize risks and guide personalized dietary and action plans. There are several important details to consider regarding preparation, monitoring, and follow up care; see below for the complete guide to inform your next steps in your healthcare journey.

Sudden shortness of breath, rapid heart rate, and dizziness may indicate anaphylaxis, a potentially fatal allergic reaction marked by hives, swelling, airway constriction, and hypotension requiring immediate epinephrine, or a panic attack, an intense fear response driving hyperventilation, chest tightness, and a gradual symptom peak that is not directly life threatening. There are many factors to consider in choosing emergency treatment versus supportive breathing and mental health care, so see below for crucial distinctions and guidance on next steps.

Angioedema and chronic hives often coexist, sharing mast cell–driven swelling and itch but differing in depth of skin involvement, underlying pathways, and treatment tiers. Management can range from second-generation antihistamines to omalizumab or bradykinin targeted agents based on your specific triggers and symptoms. There are several factors to consider: see below for complete details on pathophysiology, diagnostic steps, management strategies, emergency red flags, and personalized next steps in your healthcare journey.

Recognizing angioedema warning signs in chronic urticaria like rapid swelling of the lips, tongue or throat is vital to prevent airway obstruction and ensure timely treatment with antihistamines, corticosteroids and epinephrine. A stepwise doctor’s approach including detailed history, physical exam, lab tests, risk assessment and tailored management helps guide care, while patient education on triggers, medication adherence and emergency response is essential. There are many important details to consider; see below for the complete answer.

Chronic hives in an autoimmune subtype arise from anti-FcεRI IgG autoantibodies that cross-link high-affinity IgE receptors on mast cells and basophils, driving persistent histamine release and affecting about 30 to 40 percent of patients with chronic spontaneous urticaria. Recognizing this mechanism is crucial, as it guides the use of targeted treatments such as high-dose H1 antihistamines, omalizumab, and immunosuppressants when standard therapy fails. Multiple factors—from advanced diagnostic tests (ASST, BAT, immunoassays) to lifestyle adjustments—can impact your next steps in care, so see below for more important details that could influence your management plan.

Anti-IL-4 receptor monoclonal antibodies, such as dupilumab, block the IL-4/IL-13 pathway to reduce airway inflammation, asthma exacerbations, and steroid dependence in moderate-to-severe allergic asthma. Approved for patients with Type 2 inflammatory markers who remain uncontrolled on standard inhalers, this precision biologic requires subcutaneous injections, side effect monitoring, and insurance planning. There are many factors to consider—including eligibility criteria, dosing schedules, potential side effects, monitoring protocols, and cost support—so see below for complete details to guide your next steps with your healthcare provider.

Anti-IL-5 therapies for lung health target the cytokine IL-5 or its receptor to reduce eosinophilic inflammation in conditions like eosinophilic asthma, resulting in fewer exacerbations, lower oral steroid use, and improved lung function. However, many important details on patient selection, dosing schedules, monitoring plans, potential side effects, and how to combine these treatments with other asthma medications could affect which next steps you take in your care. See below for the complete information that could guide your decisions.

Turmeric, ginger, licorice root, and other anti-inflammatory herbs may support lung health by reducing airway inflammation and protecting tissue but can interact with medications, alter blood pressure, or trigger allergic reactions. There are several factors to consider including proper dosing, potential side effects, and knowing when to seek medical attention. See below for complete safety warnings and usage guidelines that could impact your next steps.

Antihistamine-resistant hives occur when up to four times the standard dose of second-generation H1 blockers fails to control itching welts driven by autoimmune processes, thyroid autoimmunity, infections, physical triggers or stress. Specialist next steps include a detailed history, basic and specialized tests, and add-on therapies such as omalizumab, immunosuppressants or leukotriene antagonists alongside lifestyle and trigger management. See below for a comprehensive overview of underlying causes, diagnostic approaches and personalized treatment strategies to guide your healthcare journey.

Aspirin exacerbated respiratory disease is a chronic condition characterized by the triad of asthma, chronic rhinosinusitis with nasal polyps, and sensitivity to aspirin or other NSAIDs that can rapidly trigger wheezing, congestion, and gastrointestinal distress. Doctors diagnose AERD through a detailed medical history, pulmonary function tests, nasal endoscopy or imaging, and supervised aspirin or NSAID challenge in specialized centers. Management includes avoiding COX-1 inhibiting medications, using leukotriene modifiers, corticosteroids, aspirin desensitization, biologic therapies, possible sinus surgery, and supportive measures; see below for crucial details that may influence your next steps in care.

Asthma mortality is low globally (about 0.44 deaths per 100,000 people annually) but still accounts for roughly 9–10 deaths per day in the US, with higher risks in young children, older adults, and Black and Hispanic populations. Evidence-backed prevention metrics—such as tracking symptom frequency, rescue inhaler use, peak expiratory flow readings, and maintaining ≥80% medication adherence—combined with personalized action plans and trigger control can greatly reduce severe attacks. There are several factors to consider when applying these prevention strategies and understanding your individual risk profile; see below for a comprehensive breakdown of statistics, measurable metrics, and practical next steps to guide your healthcare decisions.

Asthma-COPD overlap syndrome features mixed asthma-like reversibility and COPD-like persistent airflow limitation and requires a thorough workup that includes detailed medical history, spirometry with reversibility testing, imaging, and laboratory analyses. There are several important details to consider when interpreting test results, planning combination therapies, and monitoring exacerbations. See below for the full diagnostic steps and next healthcare actions.

Baker’s asthma and wheat allergy both result from immune reactions to wheat proteins but differ in exposure routes, affected organs, and diagnostic tests. Baker’s asthma arises from inhaling flour dust and is evaluated with spirometry, peak flow monitoring, and specific inhalation challenges, while wheat allergy follows ingestion and relies on skin prick testing, serum IgE measurements, and oral food challenges. Several factors influence the choice of tests, management strategies, and urgency of care based on your history and symptom patterns; see complete guidelines below for detailed diagnostic steps, treatment options, and when to seek further help.

Basophil counts in chronic hives can indicate disease activity, with low basophil levels often linked to more severe or antihistamine-resistant urticaria and fluctuations paralleling flares. However, basophil numbers are influenced by timing, medications, and other lab markers and are best used alongside symptom tracking and clinical assessment. For a full understanding of basophil biology, measurement ranges, clinical evidence, treatment implications, and patient tips, see below.

Distinguishing bed bug bites from chronic hives relies on differences in rash patterns, timing, lesion duration, blanching, and itch sensation, along with clues like clustered bites versus rapidly changing welts and response to antihistamines. Key signs such as nighttime itching, visible insects, or angioedema also guide accurate diagnosis. There are several factors to consider that could affect which next steps you take in your healthcare journey, so see below for more important details to ensure a correct diagnosis and targeted treatment.

Biologic injections for severe asthma are tailored based on your asthma phenotype, biomarker levels and treatment response, with common schedules ranging from every two to eight weeks to maximize symptom control and minimize flare ups. Working with your healthcare team to review your blood test results, past treatment history and insurance coverage will help you choose the right therapy and dosing interval. There are several factors to consider such as interval adjustments, missed dose management and monitoring requirements, so see below for complete details that could impact your next steps.

Researchers are exploring a range of targeted biological therapies, including anti-IgE antibodies, cytokine blockers, BTK inhibitors and CAR T methods, to prevent or blunt life-threatening anaphylaxis. There are several factors to consider about efficacy, safety and patient selection. See below for full details on these emerging treatments and other important considerations that could impact your next steps in care.

Biologics such as omalizumab target IgE and inflammatory cytokines to calm the overactive immune response that drives chronic spontaneous urticaria. This precision approach can reduce welts and itching and often allows patients to taper off high-dose antihistamines and steroids when standard therapies are insufficient. There are several important considerations including candidacy criteria, dosing schedules, efficacy timelines and safety monitoring that could affect your next steps in care; see below for complete details.

Targeted biologics block key immune mediators IgE, IL-5 or IL-4/IL-13 to significantly reduce airway inflammation, decrease severe asthma flare-ups by up to 60% and improve lung function in patients whose allergic asthma remains uncontrolled on high-dose inhaled steroids. These precision therapies also allow tapering of oral steroids and generally have a favorable safety profile with monitoring for rare allergic reactions. There are several factors to consider, including T2 inflammation markers, candidate selection and administration schedules, so see complete details below.